WEST PHARMACEUTICAL SERVICES, INC. Deferred Income Tax Expense (Benefit)
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Deferred Income Tax Expense (Benefit) of -$13.70 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-02-17
- WEST PHARMACEUTICAL SERVICES, INC. deferred income tax expense (benefit) for the quarter ending 2022-12-31 was -$22.80M.
- WEST PHARMACEUTICAL SERVICES, INC. deferred income tax expense (benefit) for the quarter ending 2022-09-30 was -$8.00M.
- WEST PHARMACEUTICAL SERVICES, INC. deferred income tax expense (benefit) for fiscal 2025 was -$13.70M.
- WEST PHARMACEUTICAL SERVICES, INC. deferred income tax expense (benefit) for fiscal 2024 was -$3.50M, a 109.33% decline from fiscal 2023.
- WEST PHARMACEUTICAL SERVICES, INC. deferred income tax expense (benefit) for fiscal 2023 was $37.50M.
- WEST PHARMACEUTICAL SERVICES, INC. deferred income tax expense (benefit) for fiscal 2022 was -$30.80M.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$13.70M 10-K · filed 2026-02-17 | |||
| 2024-12-31 | -$3.50M 10-K · filed 2026-02-17 | |||
| 2023-12-31 | $37.50M 10-K · filed 2026-02-17 | |||
| 2022-12-31 | -$22.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | -$30.80M derived: sum of 2 quarters · filed 2025-02-18 | -$30.80M 10-K · filed 2025-02-18 | |
| 2022-09-30 | -$8.00M 10-Q · filed 2022-10-27 | -$8.00M 10-Q · filed 2022-10-27 | ||
| 2021-12-31 | -$42.90M 10-K · filed 2024-02-20 | |||
| 2020-12-31 | -$5.80M 10-K · filed 2023-02-21 | |||
| 2019-12-31 | $15.30M 10-K · filed 2022-02-22 | |||
| 2018-12-31 | $900.00K 10-K · filed 2021-02-23 | |||
| 2017-12-31 | $41.70M 10-K · filed 2020-02-24 | |||
| 2016-12-31 | $21.50M 10-K · filed 2019-02-28 | |||
| 2015-12-31 | -$8.90M 10-K · filed 2018-02-26 | |||
| 2014-12-31 | $7.00M 10-K · filed 2017-02-28 | |||
| 2013-12-31 | $1.70M 10-K · filed 2016-02-26 | |||
| 2012-12-31 | $5.30M 10-K · filed 2015-02-25 | |||
| 2011-12-31 | $2.90M 10-K · filed 2014-02-27 | |||
| 2010-12-31 | -$1.80M 10-K · filed 2013-02-27 | |||
| 2009-12-31 | -$4.80M 10-K/A · filed 2012-03-01 | |||
| 2008-12-31 | $7.30M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |